During the International Nurses Society on Addictions 43rd Annual Education Conference in Baltimore, a special eight-hour buprenorphine waiver training course intended for NPs, CNM, CNS, and CRNAs will be offered.
Wednesday, Oct. 9
8:30 a.m. to 4:30 p.m.
Crowne Plaza Baltimore Inner Harbor
Room International B
This special rate and workshop are made possible through sponsorship from the Boston Medical Center Grayken Center for Addiction, and American Academy of Addiction Psychiatry (AAAP) is the DATA 2000 sponsor for this training. Funding for this initiative was made possible (in part) by grant nos. 5U79TI026556-02 and 3U79TI026556-02S1 from the Substance Abuse and Mental Health Services Administration (SAMHSA).
This eight-hour course prepares physicians, nurse practitioners, and physician assistants to prescribe buprenorphine to treat opioid use disorder. The curriculum includes the science of addiction as a brain disorder, the pharmacology of buprenorphine, and the regulatory requirements around prescribing this medication.
Attendees will learn to screen patients for treatment with buprenorphine and to manage the medication along with the patient’s other medical needs in an office setting such as a primary care clinic. The course fulfills the eight hours of the training needed to obtain a waiver to prescribe buprenorphine. The Drug Addiction Treatment Act of 2000 (DATA 2000) requires physicians to complete eight hours of approved training in order to be eligible for a waiver, and nurse practitioners and physician assistants to complete 24 hours.
Breakfast and lunch will be provided.
This is an in-person training. There will not be an option to attend via webinar.
Register now (Select Workshop Only - Workshop B)